MedTrace Logo

Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly

NCT02648776 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2016-01-11

No results posted yet for this study

Summary

The aims of this study are to (1) examine the medication use patterns of commonly prescribed hypnotics and the factors that were associated with the long-term and short-term use patterns among the elderly population in Taiwan; (2)investigate the associations of using hypnotics with the elderly patients' disease statuses, efficacy and safety, as well as its pharmacokinetic and pharmacogenetic characteristics;(3) determine the clinical, economic and humanistic outcomes of using hypnotics and the corresponding contributing factors for the elderly in Taiwan.

Conditions

  • Sleep Disorders

Interventions

DRUG

Exposure to sedative-hypnotic drugs

These patients will have been prescribed a sedative-hypnotic drug for at least one week prior to enrollment.

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Hsiang-Wen Lin, PhD · Pharmacist, Associate Professor

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31
Completion
2018-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02648776 on ClinicalTrials.gov